August 11, 2006 — The US Food and Drug Administration (FDA) has approved first-time generic formulations of an estradiol transdermal system for the treatment of menopausal symptoms and hypoestrogenism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results